The utility of serum tumor markers CEA and CA 15–3 for breast cancer prognosis and their association with clinicopathological parameters-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The utility of serum tumor markers CEA and CA 15–3 for breast cancer prognosis and their association with clinicopathological parameters

Published:2021 Issue: Volume:28 Page:100402
ISSN:2468-2942
Container-title:Cancer Treatment and Research Communications
language:en
Short-container-title:Cancer Treatment and Research Communications

Author:

Uygur Meliha Melin,Gümüş Mahmut

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference28 articles.

1. Appropriate requesting of serum tumour markers;Kilpatrick;BMJ,2009

2. Tumor markers of breast cancer: new prospectives;Kabel;J. Oncol. Sci.,2017

3. Clinical application of tumour markers: a review;Amayo;East. Afr. Med. J,2009

4. Breast cancer: insights into risk factors, pathogenesis, diagnosis and management;Kabel;J. Cancer Res. Treat.,2015

5. Ameliorative potential of fluoxetine/raloxifene combination on experimentally induced breast cancer;Kabel;Tissue Cell,2016

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic Accuracy of Cancer Antigen 15–3 as a Seromarker Among Recurrent Breast Carcinoma in Bangladesh;Cureus;2024-09-02

2. Association Between CA 15-3 and¹⁸F-FDG PET/CT Findings in Recurrent Breast Cancer Patients at a Tertiary Referral Hospital in Kenya;Journal of Nuclear Medicine;2024-08-29

3. Circulating tumor DNA in Egyptian women with breast Cancer: A marker for detection of primary cases and early prediction of recurrence;Clinica Chimica Acta;2024-08

4. The use of ctDNA MRD precision medicine surveillance after definitive treatment of early-stage, high-risk breast cancer in a radiation oncology practice: A case series;Current Problems in Cancer: Case Reports;2024-06

5. Increased blood CSF3R+ myeloid-derived suppressor cell is a predictor for breast cancer recurrence;American Journal of Cancer Research;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3